NCT04227782View on ClinicalTrials.gov

MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)

Active, not recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging

Magnetic Resonance Imaging

OTHER

Stable Isotope Study

Stable Isotope study

Trial Locations (1)

Unknown

University of Oxford, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT04227782 - MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter